NXI Therapeutics
Creating Tomorrow
NXI Therapeutics has $4.4M in recorded funding across 1 round.
- Business Model
- B2B
- Website
- nxitherapeutics.com
- Total Funding
- $4.4M
- Last Round
- $4.4M Pre-SeedJun 2024
- Rounds
- 1
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 1 funding round for this company. The full record is or through the API.
About
NXI Therapeutics develops selective immunosuppressant drugs for autoimmune disease and organ transplantation as a University of Basel spin-off.
Summary
NXI Therapeutics is a Biotech company. It has raised $4.4M in total across 1 round, most recently a $4.4M Pre-Seed round in Jun 2024.
Tech & App Stack
1 technology or app tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Jun 2024
Similar Companies
Paratek Pharmaceuticals develops and delivers innovative treatments for serious infectious diseas...
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...
Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/nxi-therapeutics"><img src="https://indexed.vc/api/badge/company/nxi-therapeutics" alt="NXI Therapeutics on Indexed.vc" width="260" height="76" /></a>